(MedPage Today) — The result was somewhat surprising
Category: News
Ocular Therapeutix, Inc. Announces Public Offering of Common Stock
BEDFORD, Mass.–(BUSINESS WIRE)–Ocular Therapeutix, Inc. (NASDAQ: OCUL) announced today that it has commenced a registered underwritten public offering of $25 million of shares of its common stock pursuant to a shelf registration statement that was previously filed with and declared effective by the Securities and Exchange Commission (SEC). All of the shares in the offering are to be sold by the Company. Cantor Fitzgerald & Co. is acting as the sole bookrunner for the offering. Before inve
Vernal Keratoconjunctivitis Global Clinical Trials Review, H2, 2016 – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Vernal Keratoconjunctivitis Global Clinical Trials Review, H2, 2016” report to their offering. The clinical trial report provides an overview of Vernal Keratoconjunctiviti…
Glaucoma Global Clinical Trials Review, H2, 2016 – Key Vendors are Novartis, Allergan, Pfizer, Santen Pharmaceutical, Aerie Pharmaceuticals, Merck, Valeant Pharmaceuticals & Kowa Company – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Glaucoma Global Clinical Trials Review, H2, 2016” report to their offering. The clinical trial report provides an overview of Glaucoma clinical trials scenario. This repor…
Viral Conjunctivitis Pipeline Insights 2017 – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Viral Conjunctivitis – Pipeline Insights, 2017” report to their offering. Viral Conjunctivitis – Pipeline Insights, 2017 provides in depth insights on the pipeline drugs a…
Ophthalmology Pipeline Database 2017 – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Ophthalmology Pipeline Database – 2017” drug pipelines to their offering. Ophthalmology Pipeline Highlights Database – 2017, provides most up-to-date information on key pi…
InFo 124M – スイス製の白内障手術用EDOF IOL
スイス・ヌーシャテル–(BUSINESS WIRE)–（ビジネスワイヤ） — Swiss Advanced Vision（SAV-IOL SA – www.sav-iol.com）は、眼内レンズ（IOL）ポートフォリオの拡大を続けており、2016年1月に発売した最初のInFoシリーズを基盤とする新しい製品ラインの投入を発表します。InFoレンズは白内障手術後に水晶体に取って代わり、視覚への不要な副作用を回避し、解像能力を保持しながら、患者に眼鏡を必要としない視力を提供するようデザインされています。 InFo 124M眼内レンズは大型の水晶体嚢が収まるよう全径が12.4 mmで設計されています。Swiss Advanced Vision のMax Boysset最高経営責任者（CEO）は、「当社はInFo 124Mによって現行の製品ラインを強化し、さらに多くの患者が当社技術の恩恵を受けられるようにします。当社は現在、一方でより廉価なソリューション、もう一方で超高級製品をそろえながら、Instant Focus®技術を引き続き利用してポートフォリオを拡大することで、白内障手術に関連
ファインデックス、愛媛大工学部・京都大医学部との共同研究により新たな検査手法を用いた視野検査システムの開発に着手
東京–(BUSINESS WIRE)–（ビジネスワイヤ） — 株式会社ファインデックス（東証一部：3649 本社：東京 代表取締役：相原輝夫、以下ファインデックス）は、国立大学法人愛媛大学（学長：大橋 裕一、以下愛媛大学）と「新規視覚特性計測法を用いた視野計測装置の研究開発」、および国立大学法人京都大学（総長：山極 壽一、以下京都大学）との「視機能評価プログラム医療機器開発研究」に着手いたしました。 当システムの開発にあたっては、愛媛大学および京都大学の各々と共同研究を行い、両研究の成果により新しい検査手法を用いた「視線誘導型視野計測システム」の製品化を図ります。愛媛大学との共同研究においては、同大学の総合情報メディアセンター川原研究室で開発された視野計測手法について、様々な視覚特性を正確に計測する技術やプログラムの研究開発を行います。 また、京都大学医学部との共同研究においては、愛媛大学と開発した視野計測プログラムについて、臨床実装や医療機器登録に向けた検討を行い医学的見地から視野異常をきたす種々の疾患に対する新たな検査手法の開発と製品価値の確立を図ることで、新たな視野検査装
Ophthalmology expert offers tips to help relieve seasonal dry eye
If your eyes feel like the Sahara desert or your vision seems blurrier than usual, don’t panic. It may just be seasonal dry eye.
Aqueous Chlorhexidine for Intravitreal Injection Antisepsis
Povidone-iodine is the preferred antiseptic for ocular procedures, but for those who have a sensitivity, is aqueous chlorhexidine a suitable alternative? Medscape Ophthalmology
Riassunto: InFo 124M – Le IOL EDOF elvetiche per la chirurgia della cataratta
NEUCHÂTEL, Svizzera–(BUSINESS WIRE)–Swiss Advanced Vision (SAV-IOL SA – www.sav-iol.com) continua ad espandere il proprio portafoglio di lenti intraoculari (IOL) con l’annuncio della disponibilità di una nuova gamma di prodotti basati sulla prima serie InFo, lanciata nel mese di gennaio 2016. Le lenti InFo, progettate per sostituire il cristallino dopo il trattamento chirurgico della cataratta, permettono ai pazienti di vedere senza occhiali evitando effetti visivi avversi indesiderabili e ma
Fluocinolone Implant Slows Retinopathy in Macular Edema
Researchers say fluocinolone implants can delay proliferative diabetic retinopathy and slow progression of diabetic retinopathy in patients with diabetic macular edema. Medscape Medical News
Some Chronic Medications Affect IOP, May up Glaucoma Risk
Use of commonly prescribed medications for chronic conditions can alter intraocular pressure (IOP), a major risk factor for the development of glaucoma, researchers from Singapore say. Reuters Health Information
Global Diabetic Macular Edema Epidemiology and Patient Flow Analysis 2017 – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Global Diabetic Macular Edema Epidemiology and Patient Flow Analysis – 2017” report to their offering. The results of the Diabetic Macular Edema patients study are announc…
Global Dry Eye Epidemiology and Patient Flow Analysis 2017 – Research and Markets
DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Global Dry Eye Epidemiology and Patient Flow Analysis – 2017” report to their offering. The results of the Dry Eye patients study are announced in this new report Global D…
InFo 124M – Swiss Made EDOF IOL for Cataract Surgery
NEUCHATEL, Switzerland–(BUSINESS WIRE)–The company Swiss Advanced Vision (SAV-IOL SA – www.sav-iol.com) continues to expand its portfolio of intraocular lenses (IOLs) announcing the launch of a new product range based on the first InFo series release…
Additional Data From BioTime’s OpRegen® Clinical Trial in Dry-AMD to be Presented at ARVO 2017
ALAMEDA, Calif.–(BUSINESS WIRE)–BioTime, Inc. (NYSE MKT:BTX), a clinical stage biotechnology company with a focus on pluripotent stem cell technologies, and its subsidiary, Cell Cure Neurosciences, Ltd., today announced that an abstract evaluating OpRegen® in patients with advanced dry Age-Related Macular Degeneration (dry-AMD) based on the ongoing Phase I/IIa clinical trial will be presented at the Association for Research in Vision and Opthalmology (ARVO) meeting taking place from May 7-11,
Gestational diabetes raises postpartum depression risk in first-time mothers
Researchers from the Icahn School of Medicine at Mount Sinai and the Karolinska Institutet have found that gestational diabetes raises the risk of postpartum depression (PPD) in first-time mothers.
Patients With Uveitis Fare Worse After Cataract Surgery
Outcomes of cataract surgery are poorer in patients with uveitis, according to new research. Reuters Health Information
New techniques and treatments show promise for eliminating retinopathy of prematurity
A mini-symposium published in the Journal of the American Association for Pediatric Ophthalmology and Strabismus provides important insights into new techniques and treatments that show promise for eliminating retinopathy of prematurity (ROP) throughou…